Eric Sjoberg
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.3MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 30, 2018 | NIH | SBIR Phase II Pharmacological Chaperone Therapy for the GM2 Gangliosidoses | $635K | Orphi Therapeutics Inc |
| Sep 18, 2017 | NIH | SBIR Phase II Pharmacological Chaperone Therapy for the GM2 Gangliosidoses | $1.5M | Orphi Therapeutics Inc |
| Sep 16, 2017 | NIH | SBIR Phase II Pharmacological Chaperone Therapy for the GM2 Gangliosidoses | $860K | Orphi Therapeutics Inc |
| Apr 1, 2015 | NIH | SBIR Phase I Pharmacological Chaperone Therapy for the GM2 Gangliosidoses | $150K | Orphi Therapeutics Inc |
| Mar 16, 2015 | NIH | SBIR Phase I Pharmacological Chaperone Therapy for the GM2 Gangliosidoses | $150K | Orphi Therapeutics Inc |
Peer ranks
Federal funding#539
Awards as PI#417
Patents#273
Companies
- Orphi Therapeutics IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.